<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T00:57:50Z</responseDate>
  <request identifier="oai:figshare.com:article/33938601" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33938601</identifier>
        <datestamp>2026-09-18T17:42:04Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_24</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Comparison of COVID-19 mortality rates and person-time among people with HIV before (March 2020 – April 2021) and during vaccine availability (May 2021 – December 2021), Florida.&lt;/p&gt;</dc:title>
          <dc:creator>Tendai N.R. Gwanzura (25073340)</dc:creator>
          <dc:creator>Mary Jo Trepka (8576319)</dc:creator>
          <dc:creator>Tan Li (404990)</dc:creator>
          <dc:creator>Levente Juhasz (9740386)</dc:creator>
          <dc:creator>Giselle A. Barreto (25073343)</dc:creator>
          <dc:creator>Shelbie Burchfield (25073346)</dc:creator>
          <dc:creator>Diana M. Sheehan (6269720)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Evolutionary Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>social vulnerability index</dc:subject>
          <dc:subject>months ); however</dc:subject>
          <dc:subject>high social vulnerability</dc:subject>
          <dc:subject>delta variant surge</dc:subject>
          <dc:subject>68 &amp;# 8211</dc:subject>
          <dc:subject>55 &amp;# 8211</dc:subject>
          <dc:subject>45 &amp;# 8211</dc:subject>
          <dc:subject>2020 &amp;# 8211</dc:subject>
          <dc:subject>13 &amp;# 8211</dc:subject>
          <dc:subject>04 &amp;# 8211</dc:subject>
          <dc:subject>19 mortality rates</dc:subject>
          <dc:subject>socially vulnerable areas</dc:subject>
          <dc:subject>months ), driven</dc:subject>
          <dc:subject>competing risks model</dc:subject>
          <dc:subject>vaccine availability period</dc:subject>
          <dc:subject>5 per 100</dc:subject>
          <dc:subject>3 per 100</dc:subject>
          <dc:subject>2021 &amp;# 8211</dc:subject>
          <dc:subject>19 vaccine availability</dc:subject>
          <dc:subject>relative hazard compared</dc:subject>
          <dc:subject>vaccine availability</dc:subject>
          <dc:subject>19 vaccines</dc:subject>
          <dc:subject>svi ),</dc:subject>
          <dc:subject>level areas</dc:subject>
          <dc:subject>final model</dc:subject>
          <dc:subject>zip code</dc:subject>
          <dc:subject>observational comparisons</dc:subject>
          <dc:subject>key subgroups</dc:subject>
          <dc:subject>inequities persisted</dc:subject>
          <dc:subject>hispanic white</dc:subject>
          <dc:subject>hispanic black</dc:subject>
          <dc:subject>elevated hazard</dc:subject>
          <dc:subject>ci 0</dc:subject>
          <dc:subject>causal effect</dc:subject>
          <dc:subject>advancing equity</dc:subject>
          <dc:subject>57 ).</dc:subject>
          <dc:subject>527 people</dc:subject>
          <dc:subject>5 vs</dc:subject>
          <dc:subject>000 person</dc:subject>
          <dc:description>&lt;p&gt;Comparison of COVID-19 mortality rates and person-time among people with HIV before (March 2020 – April 2021) and during vaccine availability (May 2021 – December 2021), Florida.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-18T17:41:56Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0358543.t001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Comparison_of_COVID-19_mortality_rates_and_person-time_among_people_with_HIV_before_March_2020_April_2021_and_during_vaccine_availability_May_2021_December_2021_Florida_p_/33938601</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
